Delivery Order SPE2DE21D7020-SPE2D625F4CVD
- Not listed
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $26,532.60 to Boston Scientific Corp for agent drug-coated balloon medical devices. The contract, issued on August 18, 2025, carries a fixed-price pricing structure with economic price adjustment provisions and has an ultimate completion date of August 25, 2025. This delivery order represents a continuation of Boston Scientific's role as a key supplier of specialized cardiovascular intervention equipment to...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $18,134.55 for agent drug-coated balloons by the Defense Health Agency's Medical Supply Chain on August 8, 2025. The delivery order, which carries an ultimate completion date of August 15, 2025, represents a competitive award with no set-aside designation. The contract employs fixed-price pricing with economic price adjustment mechanisms...
- The Defense Health Agency's Medical Supply Chain has awarded a delivery order to Boston Scientific Corp for agent drug-coated balloons, with a ceiling value of approximately $19.9K and an ultimate completion date of September 22, 2025. This fixed-price contract with economic price adjustment provisions was awarded on September 15, 2025, with no set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The work will be performed at Boston Scientific's...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order to Boston Scientific Corp for drug-coated balloons on September 10, 2025, with a contract ceiling value of $6,175 and an ultimate completion date of September 17, 2025. This fixed-price delivery order with economic price adjustment carries no set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The work will be performed at Boston Scientific's facility in Marlborough,...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order to Boston Scientific Corp on August 15, 2025, for agent drug-coated balloons, with a ceiling value of $13,590.30. This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 22, 2025, and will be performed at Boston Scientific's facility in Marlborough, Massachusetts. The award carries no set-aside designation, indicating open competition in the federal marketplace. Drug-coated...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $8,714.55 to Boston Scientific Corp for drug-coated balloons, with performance scheduled to conclude by July 25, 2025. This fixed-price delivery order with economic price adjustment represents a competitive contract with no set-aside designation. Boston Scientific, headquartered in Marlborough, Massachusetts, will perform work at its primary facility in the same location. The contract exemplifies the ongoing...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order to Boston Scientific Corp for agent drug-coated balloons with a ceiling value of $6,175. The contract is a fixed-price agreement with economic price adjustment provisions, with an ultimate completion date of August 21, 2025. This delivery order was not set aside for any specific business category and will be performed at Boston Scientific's Marlborough, Massachusetts facility. As a prime contractor, Boston Scientific is...
- The Defense Health Agency's Medical Supply Chain awarded Boston Scientific Corp a fixed-price delivery order valued at $7,524.80 for drug-coated balloon medical devices, with an ultimate completion date of August 29, 2025. The contract, which is not set-aside and uses economic price adjustment pricing, will be performed at Boston Scientific's Marlborough, Massachusetts facility. This delivery order represents a discrete procurement under the agency's broader medical device supply chain...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $21,014.55 to Boston Scientific Corp for agent drug-coated balloons, with an ultimate completion date of July 30, 2025. This fixed-price contract with economic price adjustment was issued without a set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The work will be performed at the company's facility in Marlborough, Massachusetts, where Boston Scientific manufactures...
- Boston Scientific Corp has been awarded a delivery order valued at $8,150.20 for agent drug-coated balloons under a Defense Health Agency Medical Supply Chain contract. The award, issued on September 16, 2025, with a completion date of September 19, 2025, utilizes fixed-price pricing with economic price adjustment terms. The contract carries no set-aside designation, indicating open competition in the federal marketplace. Performance will be executed at Boston Scientific's Marlborough,...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F4CVDDelivery Order
The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $6,175 to Boston Scientific Corp on September 24, 2025, for the supply of agent drug-coated balloons. The contract is a fixed-price agreement with economic price adjustment provisions and carries an ultimate completion date of October 1, 2025. Boston Scientific will fulfill this order from its Marlborough, Massachusetts facility, where the company manufactures advanced medical devices. No small business set-aside was utilized for this award, indicating open competition in the federal marketplace. Boston Scientific is a leading global medical technology firm that serves as a prime contractor across multiple federal healthcare agencies, particularly the Department of Veterans Affairs and the Defense Health Agency. The company specializes in cardiovascular intervention devices, including the drug-coated balloons specified in this delivery order, which are used in interventional cardiology procedures. This award represents a routine procurement under what is likely a broader indefinite delivery vehicle or blanket purchase agreement with the Defense Health Agency, enabling the military healthcare system to efficiently obtain critical cardiovascular intervention supplies to support patient care across military treatment facilities and the Veterans Health Administration.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 9/24/25 |